Back to Search Start Over

Immunotherapy for Post-COVID Neuropsychiatric Symptoms: The Potential of IVIG Treatment

Authors :
Satnarine, Travis
Ahmed, Areeg
Haq, Ayesha
Patel, Deepkumar
Gutlapalli, Sai Dheeraj
Hernandez, Grethel N.
Seffah, Kofi
Zaman, Mustafa Abrar
Awais, Nimra
Khan, Safeera
Satnarine, Travis
Ahmed, Areeg
Haq, Ayesha
Patel, Deepkumar
Gutlapalli, Sai Dheeraj
Hernandez, Grethel N.
Seffah, Kofi
Zaman, Mustafa Abrar
Awais, Nimra
Khan, Safeera
Source :
Journal of Medical and Health Studies; Vol. 4 No. 2; 79-85; 2710-1452
Publication Year :
2023

Abstract

This paper explores the neuropsychiatric consequences of SARS-CoV-2 (COVID-19) infection, specifically the use of intravenous immunoglobulin (IVIG) therapy in treating central nervous system (CNS) symptoms associated with COVID-19. The authors searched PubMed and Google Scholar using the keywords "IVIG" and "covid-19 neuropsychiatric symptoms" to find five articles, including three case reports, a retrospective study, and a prospective study, that detail the experiences of individuals with persistent neuropsychiatric symptoms after contracting COVID-19. The neuropsychiatric symptoms reported in the analyzed studies include sleep disturbance, exhaustion, cognitive decline, anxiety, and others. Common treatments for post-COVID neuropsychiatric symptoms include medications, cognitive behavioral therapy, and lifestyle modifications. IVIG therapy to manage CNS symptoms of COVID-19 has shown mixed results in studies, with some showing positive effects while others remain inconclusive. Further research is needed to understand this therapy's potential benefits and limitations fully.

Details

Database :
OAIster
Journal :
Journal of Medical and Health Studies; Vol. 4 No. 2; 79-85; 2710-1452
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1376781288
Document Type :
Electronic Resource